Irving Weissman

Director at Pheast Therapeutics.

Earliest Form D on file: Apr 2025

2 filings at 1 company

Pheast Therapeutics

Biotech, Redwood City CA

Director

Biotech, Redwood City CA

Signed
Named
Size is amount sold, up to $30M

Filings

2

Oct 16, 2025
Equity, option to acquire, security to be acquired, named · Form D
$24.6M
of $40M
Oct 16, 2025
Equity, option to acquire, security to be acquired
Named, Director
$24.6M
$40M
Form D
Apr 10, 2025Amendment
Equity, named · Form D
$75.25M
of $75.25M
Apr 10, 2025Amendment
Equity
Named, Director
$75.25M
$75.25M
Form D

Network

At Pheast Therapeutics

6 people

Roy Maute
Together on 2 filings
Executive Officer, Director, signed as Chief Executive Officer
Amira Barkal
Together on 2 filings
Director
Jacob Vogelstein
Together on 2 filings
Director
Steven Gillis
Together on 2 filings
Director
Raphael Rousseau
Together on 1 filing
Executive Officer
Thomas Marty
Together on 1 filing
Executive Officer